Inhibition of mTOR (mammalian target of rapamycin), selective suppression of the IRE1–JNK signaling pathway, restoration of hyperlipidemia-induced ER stress/NF-κB-mediated pathway. Here, NFKB1 is linked to hyperlipidemia.